Category Archives: Stem Cell Human Trials

(Part 3 of 4) Cardiovascular Therapies: Spotlight on Stem Cell Research "Stem Cell Research: Where are we with Peripheral Arterial Disease (PAD)" On March 10, 2011, Yung-Wei Chi, OD, spoke about a recently launched clinical trial that using a patient's own stem cells to help prevent amputations due to peripheral arterial disease. Chi is an associate professor of medicine at the UC Davis Vascular Center. Chi was introduced by Claire Pomeroy, MD, MBA, vice chancellor for Human Health Sciences at UC Davis and dean of the UC Davis School of Medicine. Read the original: Cardiovascular Therapies: Spotlight on Stem Cell Research - Yung-Wei Chi … Continue reading →

(Part 3 of 4) Myeloid proliferative diseases are life threatening blood disorders that can lead to acute leukemia. Using stem cells, the laboratory of Dr. Catriona Jamieson showed that a specific small molecule could halt these diseases. Excerpt from: Leukemia: Spotlight on Stem Cell Research - Patient Stories … Continue reading →

(Part 4 of 4) Tony Ferrandino spoke at the "Spotlight on Batten Disease," an educational event presented at the CIRM Governing Board Meeting on August 13, 2008. Ferrandino's son, Drew, was diagnosed with Batten disease in January 2007 More: Batten Disease: Spotlight on Stem Cell Research - A Father's Story … Continue reading →

abclocal.go.com Carolyn Johnson In a matter of days, a Bay Area company will launch a unique stem cell trial that could produce a major breakthrough. It may offer the first hope of someday freeing paralyzed patients from their wheelchairs. Paralysis patient Roman Reed has never let go of the dream of walking again. The rest is here: Stemcells come alive: Fix Mouse with severed spine ABCnews … Continue reading →

Shares of StemCells (STEM) are up 5.85% after the company announced that it will initiate the Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cells in chronic spinal cord injury. The trial is now open for enrollment, and will accept patients with both complete and incomplete degrees of paralysis who are three to twelve months post-injury. It is being conducted in Switzerland at the Balgrist University Hospital, University of Zurich Continue reading here: StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury … Continue reading →

Phase 1 of the world's first clinical trial using human embryonic stem cell therapy was initiated in October for spinal cord injury patients. See the rest here: First hESC Therapy Clinical Trial … Continue reading →

http://www.facingdisability.com For Families Facing Spinal Cord Injuries View original post here: Stem-Cell Research on Animals … Continue reading →

Doctors at Moorfields Eye hospital in London carried out Europe's first clinical trial using human embryonic stem cells. Go here to read the rest: Toonari Post Health News: Europe's first clinical trial using human embryonic stem cells … Continue reading →

(Part 3 of 4) Ed Baetge, Ph.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Baetge discussed Novocell, Inc.'s (now ViaCyte) efforts to generate replacement pancreatic beta islet cells from human embryonic stem cells for the development of cell-based diabetes therapies Excerpt from: Diabetes: Spotlight on Stem Cell Research - Ed Baetge … Continue reading →

Human trials of stem cell therapy for post-heart attack patients have raised as many questions as they have answered — because while the patients have tended to show some improvement in heart function, the stem cells do not appear to turn into heart cells or even survive. But in a featured paper published in the latest edition of the journal Cell Stem Cell, Harvard Stem Cell Institute (HSCI) researchers at Brigham and Women's Hospital (BWH) provide a solution to the puzzle — and what appears to be a new use for stem cells. More here: How to Mend a Broken Heart … Continue reading →